POPULARITY
What if your healthcare team already knew what happened during your hospital stay — before you even explained it? What if someone on your care team noticed you were struggling on a Saturday and simply showed up? In this episode, Jamie sits down with Christopher Laffey, Nurse Practitioner at Your Health, to break down what a truly connected, proactive model of care actually looks like when it's working. Christopher practices in North Charleston, SC, where his team — nurses, therapists, social workers, community health workers, and more — functions less like a traditional office practice and more like a living, breathing safety net woven around each patient's real life. What you'll hear in this episode: Why most patients are failing not because nobody cares, but because the system itself is fragmented — and what doing it differently actually looks like on a Tuesday morning The real difference between "patient-centered" as a marketing phrase and patient-centered as a daily practice (hint: it involves seeing the medication bottles on the kitchen table) A powerful real-life story of a bedbound patient whose caregiver suddenly disappeared — and how the team mobilized over a weekend, on their own time, to prevent a hospitalization The single mindset shift every clinician needs to make the transition from visit-based thinking to longitudinal care Why "value-based care" doesn't mean discounted care — it means the organization is accountable for your outcomes, not just your appointments If you've ever left a doctor's appointment feeling more confused than when you walked in, this episode will show you what healthcare can feel like when it's actually designed around you. www.YourHealth.Org
What is required from both instructors and students to teach and learn clinical judgment? Our EMS profession is a place where right answers are not always cut and dry and grace might be the most important skill in the room. In this episode, guest Jeff Anderson, Paramedic Program Director at Bossier Parish Community College joins hosts Maia Dorsett, Hilary Gates and Ginger Locke for an honest, humbling conversation about what it really takes to teach clinical judgment. They dig into the gap between what students hear in the classroom and what they absorb in the field, why preceptors and educators can be in tension and how educators can struggle with ego and reactivity. They share real stories from their programs, talk through how they handle their own emotional reactions, and offer practical advice for educators trying to make peace with a profession that doesn't fit neatly into a protocol. Whether you're a program director, a preceptor, or someone still figuring out how to teach the grey, this one's for you.Rob Lawrence provides the "Rob Recap."Mentioned in the episode:Daniel Kahneman, "Thinking Fast and Slow": https://www.amazon.com/Thinking-Fast-Slow-Daniel-Kahneman/dp/0374533555Pat Croskerry, Clinical Decision Making: https://www.nejm.org/doi/full/10.1056/NEJMp1303712The EMS Educator is published on the first Friday of every month! Be sure to turn on your notifications so you can listen as soon as the episode drops, and like/follow us on your favorite platform.Check out the Prodigy EMS Bounty Program! Earn $1000 for your best talks! https://www.prodigyems.com/bounty-programGet your CE at www.prodigyems.com. Follow @ProdigyEMS on FB, YouTube, TikTok & IG.
When does urodynamics actually change management and when is it unnecessary? In BackTable Urology's latest collaboration with the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), Dr. Howard Goldman and Dr. David Ginsberg join Dr. Giulia Ippolito to discuss the evidence-based use of urodynamics across a range of clinical scenarios. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction 05:04 - Case: Male Urinary Retention12:38 - Case: Failed Sling18:44 - Case: Parkinson's OAB21:50 - Case: Post-Prostatectomy26:48 - Prolapse Without Urodynamics32:29 - Obstruction Workup36:16 - Refractory OAB42:49 - Interstitial Cystitis45:18 - Recurrent UTI Evaluation50:16 - Conclusions --- More about this episode They review guideline-driven indications and limitations of urodynamic testing, emphasizing that many common conditions do not routinely require testing. Through case-based discussion, they highlight situations where urodynamics can meaningfully inform care, such as complex neurogenic patients and cases requiring differentiation between obstruction and detrusor underactivity. The conversation highlights the importance of clinical judgment, targeted use of adjuncts such as uroflow, and aligning testing with decision-making to optimize patient outcomes.This podcast is supported by the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU). --- Resources Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study)https://pubmed.ncbi.nlm.nih.gov/34702331/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Assembled Intelligence and InVibe surveyed 150 U.S.-based physicians across 12 specialties to understand how healthcare professionals find, evaluate and act on clinical information in an increasingly fragmented digital environment. The research reveals a four-stage digital journey, a conditional and growing role for AI tools and a meaningful generational divide in how physicians approach new technology. In this conversation, we sit down with Assembled Intelligence's Chuck Hemann and InVibe's Christopher Farina to discuss what the data means for pharma marketers and communicators trying to reach HCPs on their terms. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
In this episode, Dan is joined by Carlos Jimenez to discuss MSK Ultrasound in physical therapy practice, including assessment, intervention selection, and more. Carlos Jimenez, DPT, RMSK, CPSS, is a physical therapist, educator, and founder of Pura Health, an educational platform focused on advancing MSK ultrasound training for clinicians. With over a decade of experience in sports medicine and rehabilitation, Carlos specializes in integrating diagnostic imaging into real-world clinical decision making. He provides hands-on workshops, mentorship, and online education for PTs, athletic trainers, and sports medicine professionals. Carlos is also a PhD candidate at Amsterdam University and has been recognized by Inteleos for his contributions to ultrasound education.Instagram: @c_jimenez31 | @pura.health_ultrasoundSeason 7 of the Braun Performance & Rehab Podcast is proudly supported by Pura Health, bringing ultrasound into every clinician's hands. Learn more at purahealth.net and @pura.health_ultrasound.Additional support provided by Firefly Recovery, the official recovery partner of Braun Performance & Rehab (recoveryfirefly.com), and Dr. Ray Gorman of Engage Movement. Learn how to grow your income beyond sessions—follow @raygormandpt on Instagram and DM “Dan” for a free breakdown of the blended practice model.Episode Affiliates: Airbands BFR (Coupon Code: DANIELBRAUN for 10% off), MoboBoard (BRAWNBODY10), AliRx (DBraunRx), MedBridge (BRAWN)If you enjoyed this episode, share it with someone who would benefit and leave a 5-star review.Explore more from Dan at linktr.ee/braun_pr.
In this episode of Drug Diversion Insights, Terri sits down with Dr. Don Teater, a leading expert in pain management and addiction medicine, for a deeper exploration of buprenorphine—through both a clinical and neuroscience lens.Together, they unpack what happens in the brain after opioid exposure and how those changes shape treatment decisions for patients with and without substance use disorder.This conversation tackles some of the most complex and practical questions in addiction medicine, including:• How opioid exposure alters brain function over time• Differences in response between individuals with and without substance use disorder• When to consider abstinence-based treatment vs. buprenorphine• Whether healthcare professionals can safely return to work while on buprenorphine• Considerations after completing abstinence-based recoveryThey also explore emerging research on buprenorphine in postoperative pain management, including its safety advantages and the challenges clinicians face with dosing and efficacy in high-tolerance patients.This is a nuanced, evidence-based discussion designed for clinicians, pharmacy leaders, opioid stewardship teams, and healthcare decision-makers navigating complex treatment and policy decisions.More from Rxpert Solutionshttps://www.rxpert.solutions/?utm_source=youtube&utm_medium=insights&utm_campaign=don_buprenorphine
Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course explains what shared clinical decision‑making means in the context of immunizations, examines how it affects pediatric vaccine discussions, and highlights opportunities for pharmacists to support informed, individualized conversations with patients and caregivers. You will gain clarity on how to apply shared clinical decision‑making principles—alongside proven health coaching strategies—to strengthen patient trust and foster more meaningful dialogue in pharmacy practice.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTElizabeth Skoy, PharmD, RPhProfessorNorth Dakota State University Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe shared clinical decision-making and how it applies to recent pediatric vaccine recommendations.2. Identify the pharmacist's roles in counseling, education, and facilitating shared clinical decision-making conversations with patients and caregivers. Rachel Maynard and Elizabeth Skoy have no relevant financial relationships with ineligible companies to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-26-077-H01-PInitial release date: 3/2/2026Expiration date: 3/2/2027Additional CPE details can be found here.
Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course explains what shared clinical decision‑making means in the context of immunizations, examines how it affects pediatric vaccine discussions, and highlights opportunities for pharmacists to support informed, individualized conversations with patients and caregivers. You will gain clarity on how to apply shared clinical decision‑making principles—alongside proven health coaching strategies—to strengthen patient trust and foster more meaningful dialogue in pharmacy practice.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTElizabeth Skoy, PharmD, RPhProfessorNorth Dakota State UniversityGET CE FOR THIS LISTENING!The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that's less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll. PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe shared clinical decision-making and how it applies to recent pediatric vaccine recommendations.2. Identify the pharmacist's roles in counseling, education, and facilitating shared clinical decision-making conversations with patients and caregivers. Rachel Maynard and Elizabeth Skoy have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 HrUAN: 0107-0000-26-077-H01-PInitial release date: 3/2/2026Expiration date: 3/2/2027Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
Victor is a 12-year-old male who presents with a limp and groin pain. The hip rests in external rotation, and hip flexion produces obligatory external rotation. Which of the following should the physical therapist initiate FIRST?A) Begin hip strengthening and gait trainingB) Stretch hip internal rotators and adductorsC) Make the patient non–weight bearing and refer urgentlyD) Initiate aquatic therapy for pain-free ROMJoin the FREE Facebook Group: www.nptegroup.com
CME credits: 0.75 Valid until: 13-02-2027 Claim your CME credit at https://reachmd.com/programs/cme/evidence-at-a-glance-the-totality-of-evidence-impacting-clinical-decision-making-in-patients-with-hfref-without-a-recent-worsening-event/54634/ Patients with heart failure with reduced ejection fraction (HFrEF) who have not experienced a recent worsening event pose a major clinical challenge: persistent and under-recognized cardiovascular (CV) risk. Recent findings show that these patients carry significant annual rates of CV death and heart failure (HF) hospitalization, despite adherence to quadruple guideline-directed medical therapy (GDMT) and device support. For cardiologists, the challenge is twofold: accurately identifying high-risk individuals without overt clinical deterioration and knowing when and how to intensify therapy in patients who appear stable but remain vulnerable. Recent data show that soluble guanylate cyclase (sGC) may provide significant reductions in CV death and all-cause mortality, particularly in individuals with moderately elevated NT-proBNP (≤6,000 pg/mL). These findings are especially important because this population is far more common in routine cardiology practice and has historically been overlooked in discussions of additional therapy. However, cardiologists often underestimate risk in these ambulatory patients and may hesitate to add therapies when GDMT appears to be working well. Tune in to learn best practices for patient selection and the implementation of added sGC therapy.
In this episode of the Innovations and Clinical Implementation podcast recorded at LongevityFest 2025, host Dr. Lexi Gonzales explores the intersection of AI and gut health with Dr. Helen Messier, a physician and molecular immunologist who serves as the Chief Medical and Science Officer at Fountain Life; Dr. Leo Grady, the founder of Jona and an AI expert who previously led the team achieving the first FDA approval for an AI product in pathology; and Dr. Lawrence Kosinski, a gastroenterologist and founder of Sonar MD who is a national leader in value-based care. The panel discusses how Jona's AI platform processes over 220,000 studies to identify dysbiotic patterns that antedate clinical disease—ranging from metabolic liver disease and colon polyps to Parkinson's and cardiovascular issues linked to TMAO—thereby moving clinical focus from "symptoms to systems". The experts emphasize the mechanism of the gut-brain axis, noting that metabolites like butyrate derived from soluble fiber are essential for stabilizing the blood-brain barrier and DNA, while warning that popular GLP-1 agonists, though effective for weight loss, can "collapse" microbiome diversity and require careful monitoring. For access to episode resources, click HERE.
Digital Health Talks - Changemakers Focused on Fixing Healthcare
As AI systems increasingly influence clinical decisions—from risk stratification to treatment recommendations—healthcare leaders face a critical question: When can we safely rely on AI, and when must human judgment remain in the loop?Professor Vasant Dhar, NYU Stern professor, veteran AI researcher, and author of the newly released Thinking With Machines: The Brave New World of AI, joins Digital Health Talks to deliver what healthcare executives urgently need: a practical framework for evaluating AI reliability, recognizing model blind spots, and designing guardrails that actually work.With decades of experience bringing machine learning to high-stakes environments and over one million downloads of his Brave New World podcast, Professor Dhar offers rare clarity on the mounting tension between rapidly advancing AI capabilities and our ability to evaluate their trustworthiness. Healthcare CIOs, CMIOs, and technology leaders will walk away with actionable insights for governing AI deployment—not just soundbites.Vasant Dhar, Author, Thinking With Machines: The Brave New World of AIMegan Antonelli, Chief Executive Officer, HealthIMPACT
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Clinical Decision-Making of Artificial Intelligence vs Medical Professionals in Patients With Syncope.
On a cold January day in South Carolina, Jamie and Matt Staub unpack why focus is one of the most underrated leadership skills—especially in healthcare, where everything can feel urgent. They break down how leaders decide what deserves attention, how to “push pause” on non-emergencies, and why coaching people through problems is often more effective than absorbing them. The conversation also explores decision fatigue, the difference between being busy and being focused, the role of habits (including insights from Atomic Habits), and how boundaries protect the work that actually moves the mission forward. Along the way, they normalize attention struggles, reframe “failure” as part of growth, and offer practical ways to stay aligned to goals without losing empathy or accessibility.
Join Elevated GP: www.theelevatedgp.com Register for the live meeting: https://www.theelevatedgp.com/ElevationSummit Download the Injection Molding Guide: https://www.theelevatedgp.com/IMpdf Episode Description In part two of this in-depth conversation, Dr. John Kois moves beyond theory and into clinical application, tackling the questions every restorative dentist eventually faces: Who is actually a high-risk occlusal patient? How do we distinguish past adaptation from active breakdown? And why do so many "standard solutions" fail to prevent restorative complications? Building on the foundational concepts from part one, this episode focuses on how occlusion shows up in day-to-day practice—and how dentists can make more informed decisions before committing to complex restorative or implant treatment. Dr. Kois explains why visual wear alone is an unreliable predictor of risk, how to identify whether wear is active versus inactive, and why patient symptoms often tell a more important story than what we see on models or scans. A major theme of this conversation is closing the gap between chairside evaluation and real-world function. Dr. Kois challenges common habits—such as adjusting restorations with patients fully reclined, relying solely on articulating paper marks, or reflexively prescribing nightguards—and explains why these approaches often miss the true etiology of failure. Instead, he emphasizes evaluating occlusion in positions and movements that reflect how patients actually chew, speak, and function throughout the day. In this episode, you'll learn: How to identify true high-risk occlusal cases before restorative treatment begins Why active wear and patient-reported change matter more than historical attrition How muscle symptoms, mobility, and joint loading influence predictability When nightguards and Botox may mask symptoms rather than solve the problem Why larger restorative and implant cases demand a deeper understanding of jaw position, tooth fit, and functional pathways Dr. Kois also shares candid insights on emerging technologies such as jaw tracking—where they add value, where they fall short, and why they are most impactful in comprehensive and full-arch cases rather than routine dentistry. The discussion highlights an important truth: many restorative failures are not material failures, but diagnostic failures rooted in incomplete occlusal assessment. The episode closes with a powerful reflection on learning, clinical growth, and professional development—distinguishing information from knowledge, and knowledge from wisdom. Dr. Kois outlines the progression from skepticism to commitment, underscoring why true clinical mastery requires not just understanding concepts, but applying them consistently over time. Together, parts one and two form a cohesive framework for thinking differently about occlusion—one grounded in physiology, adaptation, and long-term predictability. If you're aiming to move beyond bread-and-butter dentistry and into more complex, fulfilling clinical work, this conversation provides essential perspective on how to do so more thoughtfully and successfully.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/AAPA information, and to apply for credit, please visit us at PeerView.com/GKD865. CME/MOC/EBAH/AAPA credit will be available until January 4, 2027.Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options & Modern Clinical Decision-making in Newly Diagnosed Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Mantle Cell Lymphoma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/AAPA information, and to apply for credit, please visit us at PeerView.com/GKD865. CME/MOC/EBAH/AAPA credit will be available until January 4, 2027.Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options & Modern Clinical Decision-making in Newly Diagnosed Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Mantle Cell Lymphoma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/AAPA information, and to apply for credit, please visit us at PeerView.com/GKD865. CME/MOC/EBAH/AAPA credit will be available until January 4, 2027.Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options & Modern Clinical Decision-making in Newly Diagnosed Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Mantle Cell Lymphoma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/AAPA information, and to apply for credit, please visit us at PeerView.com/GKD865. CME/MOC/EBAH/AAPA credit will be available until January 4, 2027.Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options & Modern Clinical Decision-making in Newly Diagnosed Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Mantle Cell Lymphoma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/AAPA information, and to apply for credit, please visit us at PeerView.com/GKD865. CME/MOC/EBAH/AAPA credit will be available until January 4, 2027.Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options & Modern Clinical Decision-making in Newly Diagnosed Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Mantle Cell Lymphoma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/AAPA information, and to apply for credit, please visit us at PeerView.com/GKD865. CME/MOC/EBAH/AAPA credit will be available until January 4, 2027.Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options & Modern Clinical Decision-making in Newly Diagnosed Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Mantle Cell Lymphoma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.
In this episode, Solomon Moshkevich, president of clinical diagnostics at Natera, discusses how molecular data, MRD testing, and AI-driven tools are transforming clinical decision making across oncology, prenatal care, and chronic kidney disease. He shares insights on evidence generation, system integration, and the opportunities ahead for more personalized, cost-effective care.This episode is sponsored by Natera.
What if you could transform the future of military medicine with the power of AI and technology? Join us for a captivating conversation with retired Navy Master Chief and Independent Duty Corpsman Joe Espinosa, who takes us through his remarkable journey in military healthcare. From his early days navigating the austere environments with the 2nd Battalion, 1st Marines, to becoming a strategic leader shaping the hospital corps, Joe offers invaluable lessons on adaptability, preparation, and the critical balance between clinical confidence and humility. Listen as Master Chief Espinosa shares his pivotal experiences on smaller Navy ships and the USS Stockdale, where he honed skills in resource management and prioritization—an essential foundation for his role as Force Medical Master Chief. His insights into leadership are enriched by real-world frontline experiences, underscoring the vitality of robust support systems for those serving in combat zones. A decisive encounter with a Master Chief mentor propelled Joe into a leadership role, ultimately guiding the strategic direction of the corpsman community and championing the integration of healthcare technology with T6 Health Systems. Explore the future of military healthcare as Joe discusses the integration of AI and predictive logistics to enhance decision-making and improve survivability in the most critical situations. Delve into the innovative developments aiming to address communication challenges in deployed healthcare systems and the seamless integration of technologies like MHS Genesis. With an emphasis on how emerging tools can support the military's medical personnel, this episode serves as a beacon for understanding the evolving landscape of military medicine and the pivotal role technology plays in shaping its future. Chapters: (00:04) Master Chief Espinosa's Path in Military Medicine (11:58) Healthcare Leadership and Strategic Planning (20:58) Transition and Future of Military Medicine (29:51) Future of Military Healthcare Communication (35:41) Software Development and Military Healthcare (40:23) AI Integration in Military Healthcare (45:17) Future Developments and Challenges in Military Healthcare Chapter Summaries: (00:04) Master Chief Espinosa's Path in Military Medicine Retired Navy Master Chief Joe Espinosa shares his journey in military medicine, emphasizing mentorship and the need for innovation and technology. (11:58) Healthcare Leadership and Strategic Planning Transition from smaller to larger ships, managing medical supplies, frontline experiences, unexpected path to leadership. (20:58) Transition and Future of Military Medicine Enlisted voices shape military medical systems and face challenges transitioning to civilian life, but can use leadership skills in new roles. (29:51) Future of Military Healthcare Communication Improving communication in deployed military healthcare systems with bi-directional feedback and innovative solutions like animated QR codes. (35:41) Software Development and Military Healthcare MHS Genesis integrates with other systems, ensuring seamless transfer of healthcare records for veterans in military and VA services. (40:23) AI Integration in Military Healthcare Technology and healthcare intersect in military and civilian settings, with AI and wearables aiding decision-making for medical personnel. (45:17) Future Developments in Military Healthcare The role of technology in healthcare, predictive logistics for medical supply management, and transitioning from military to civilian healthcare technology. Balancing functionality and resource efficiency in military healthcare through agile development and user feedback. Take Home Messages: Intersection of Military Medicine and Technology: The episode explores the transformative impact of technology on military medicine, highlighting how advancements like AI and predictive logistics are revolutionizing communication and decision-making in challenging environments. This integration empowers medical personnel, especially junior corpsmen, to enhance their clinical decision-making and improve patient outcomes. Mentorship and Leadership Development: Emphasizing the importance of mentorship, the episode discusses how strategic planning and resource management are vital for effective healthcare leadership. Experiences from frontline medical roles significantly shape leaders, underscoring the need for adaptability and open communication within the military healthcare system. Navigating Career Transitions: Transitioning from a military to a civilian career can be challenging. The episode offers insights into recognizing the value of leadership and problem-solving skills gained in the military and encourages an open-minded approach to exploring diverse career opportunities beyond traditional paths. Improving Healthcare Communication: Addressing longstanding communication challenges in deployed settings, the episode discusses innovative solutions like bi-directional communication systems and animated QR codes that ensure seamless information transfer, enhancing the overall experience for medical personnel and patients in disconnected environments. Future of Military Healthcare: The episode envisions a future where technology, including mobile devices and AI, plays a crucial role in healthcare delivery. It discusses the potential for real-time data capture and analysis to alleviate cognitive burdens on healthcare providers, fostering confidence and improving decision-making in critical situations. Episode Keywords: Military medicine, healthcare innovation, AI integration, Joe Espinosa, War Docs podcast, frontline experiences, medical leadership, T6 Health Systems, predictive logistics, healthcare technology, Navy Master Chief, mentorship in healthcare, medical department setup, medical resource management, communication in healthcare, AI in military medicine, clinical decision support, military healthcare systems, medical mentorship, operational medicine Hashtags: #MilitaryMedicine #AIinHealthcare #HealthcareInnovation #FrontlineMedicine #JoeEspinosa #MentorshipInMedicine #WarDocsPodcast #PredictiveLogistics #MedicalLeadership #HealthcareTechnology **This Episode was supported by an Educational Grant from one of our WarDocs Sponsors- T6 Health Systems** Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation. Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms. Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast
Nicholas C Spies, Embracing Generative Artificial Intelligence as a Support Tool for Clinical Decision-Making, Clinical Chemistry, Volume 71, Issue 11, November 2025, Pages 1178–1179, https://doi.org/10.1093/clinchem/hvaf084
Our 52nd episode of QuidelOrtho Science Bytes features George Wierschem, Senior Global Product Manager – informatics, discussing how informatics is transforming clinical labs. From streamlining workflows to strengthening cybersecurity, informatics helps labs turn data into decisions – faster, smarter and more securely. George shares how modern platforms improve lab efficiency, ensure data integrity and support better patient outcomes through centralized access, automation and accountability. About Our Speaker: George Wierschem Senior Global Product Manager for informatics at QuidelOrtho George is a trained medical technologist with more than 30 years of laboratory experience. Over the first half of his career, George worked in a number of community-based hospitals progressing from bench technologist into leadership positions. In 2010, George entered the in vitro diagnostics industry, where he's been able to leverage his strong laboratory experience in consulting, product development and product management roles. Currently, George is helping to support legacy QuidelOrtho informatics platforms while also developing several innovative next-generation solutions. George holds an MBA with a healthcare administration specialization and is certified in Lean Six Sigma and change management.
CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Comprehensive-Biomarker-Testing-in-mBC-Informs-Clinical-Decision-Making/37332/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute to breast cancer, markedly reducing cell proliferation, promoting apoptosis, inhibiting angiogenesis, and ultimately preventing tumor formation and progression. In hormone receptor–positive (HR+), activating PIK3CA mutations occur in approximately 35% to 40% of patients and a variable prevalence across BC subtypes. Testing is thus crucial to ensure appropriate treatment selection. The development of PI3K-targeted agents may revolutionize the treatment landscape for HR+, HER2- metastatic breast cancer (mBC, and due to the recent approval of inavolisib, clinicians must be apprised of both the clinical evidence and best practices regarding the use of this agent. This activity has been designed to review the role of the PI3K-AKT-mTOR pathway in breast cancer, the importance of testing when making clinical decisions, and the role of PI3K-targeted therapies in HR+, HER- mBC.
CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Comprehensive-Biomarker-Testing-in-mBC-Informs-Clinical-Decision-Making/37332/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute to breast cancer, markedly reducing cell proliferation, promoting apoptosis, inhibiting angiogenesis, and ultimately preventing tumor formation and progression. In hormone receptor–positive (HR+), activating PIK3CA mutations occur in approximately 35% to 40% of patients and a variable prevalence across BC subtypes. Testing is thus crucial to ensure appropriate treatment selection. The development of PI3K-targeted agents may revolutionize the treatment landscape for HR+, HER2- metastatic breast cancer (mBC, and due to the recent approval of inavolisib, clinicians must be apprised of both the clinical evidence and best practices regarding the use of this agent. This activity has been designed to review the role of the PI3K-AKT-mTOR pathway in breast cancer, the importance of testing when making clinical decisions, and the role of PI3K-targeted therapies in HR+, HER- mBC.
In this episode, Dr. Sandra Pagenta, DNP APRN interviews Dr. Anne Meneghetti, an MD and physician executive at Epocrates, discussing her journey in medicine and the impact of the Epocrates app on clinical practice. They explore the app's features, its role in reducing medical errors, and how it supports nurse practitioners in making informed decisions at the point of care. The conversation also touches on the importance of patient education, the shift towards individualized care, and the future of technology in healthcare.Anne Meneghetti, MD: https://www.linkedin.com/in/anne-meneghetti-395504195/Check out Epocrates: https://www.epocrates.com/ CODE: SUCCESSTDC Group Live Webinar Link: https://registration.socio.events/e/apcriskCheck out our eBooks designed specifically for NP students navigating the clinical setting! https://bit.ly/SuccessNPebookFollow us on instagram: @thesuccesnpGo to our website www.successnps.com
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EPE865. CME credit will be available until September 16, 2026.Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent medical education grant from Jazz Pharmaceuticals.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EPE865. CME credit will be available until September 16, 2026.Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent medical education grant from Jazz Pharmaceuticals.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EPE865. CME credit will be available until September 16, 2026.Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent medical education grant from Jazz Pharmaceuticals.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EPE865. CME credit will be available until September 16, 2026.Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent medical education grant from Jazz Pharmaceuticals.Disclosure information is available at the beginning of the video presentation.
In today's episode, we spoke with Scott Kopetz, MD, PhD, FACP, about the use of circulating tumor DNA (ctDNA) in patients with colorectal cancer (CRC). Dr Kopetz is the deputy chair for Translational Research and a professor in the Department of Gastrointestinal (GI) Medical Oncology in the Division of Cancer Medicine, as well as the leader of the Department of Cancer Center Support Grant in the GI Program, the TRACTION medical director in the Division of Therapeutics Discovery, and the associate vice president for Translational Integration at The University of Texas MD Anderson Cancer Center in Houston, Texas. In our conversation, Dr Kopetz discussed the high positive predictive value of ctDNA assays, which indicate disease presence when positive. He emphasized clinical trials that have shown strong prognostic implications with this type of assay, as well as study findings that demonstrated that ctDNA results could reduce chemotherapy use without compromising efficacy. Additionally, he noted the potential significance of ongoing trials that are exploring the use of ctDNA to guide therapy. Overall, he explained that ctDNA testing is becoming a standard in clinical practice for colorectal cancer.
Host Mikalyn DeFoor, MD Guest interviewee Arianna L. Gianakos, DO, discussing her research article, “Can ChatGPT-4 Diagnose and Treat Like an Orthopaedic Surgeon? Testing Clinical Decision Making and Diagnostic Ability in Soft-Tissue Pathologies of the Foot and Ankle” from the August 15, 2025 issue Article summarized from the August 1, 2025 issue Research article “Patients With Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors Undergoing Total Knee Arthroplasty Are at Increased Odds for a Number of Postoperative Adverse Events But Reduced Risk of Transfusion” Articles summarized from the August 15, 2025 issue Review article “Management and Return to Play of the Elite Athlete for Common Sports-Related Injuries About the Ankle” Follow this link to download these and other articles from the August 1, 2025 issue of JAAOS and the August 15, 2025 issue of JAAOS. The JAAOS Unplugged podcast series is brought to you by the Journal of the American Academy of Orthopaedic Surgeons and the AAOS Resident Assembly.
Do you know the data well enough to answer patients' questions? Data, workflows, and protocols for successful implementation. Credit available for this activity expires: 5/27/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002541?ecd=bdc_podcast_libsyn_mscpedu
In this conversation, Dr. Jennie Berkovich and Dr. Alan Rozanski explore the intricate relationship between stress, optimism, and cardiac health. They discuss the impact of chronic stress on cardiovascular disease, the importance of resilience, and how positive mindsets can promote longevity. The dialogue emphasizes the need for a holistic approach to health that includes behavioral management, mindfulness, and exercise. Dr. Rozanski shares insights on how to effectively communicate these concepts to patients, highlighting the significance of time management in maintaining health. The conversation concludes with a look towards the future of cardiology and patient education.Dr. Alan Rozanski is Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Chief Academic Officer, Executive Director of Cardiac Education and Fellowship Training Programs, and Director of Nuclear Cardiology for the Department of Cardiology at Mount Sinai St. Lukes.A graduate of Yale University and the Tufts University School of Medicine, Dr. Rozanski completed his Internal Medicine and Cardiology Fellowship training at Mount Sinai Hospital and a fellowship in Nuclear Medicine at Cedars-Sinai Medical Center in Los Angeles.While at Cedars-Sinai Medical Center, Dr. Rozanski founded a large multi-disciplinary program in Preventive and Rehabilitative Cardiology and initiated research which helped lead to the creation of a new field of Behavioral Cardiology. This led to a prestigious Sabbatical Fellowship from the MacArthur Foundation to study the determinants of health-promoting and health-damaging behaviors alongside many leading behavioral clinicians across the nation.In 1990, Dr. Rozanski joined the cardiology staff of St. Lukes/Roosevelt Hospital (now Mount Sinai St. Lukes and Mount Sinai West Hospitals) where he eventually served as Chief of Cardiology before assuming his current positions.Dr. Rozanski is noted for his unique clinical and academic focus and novel research that uniquely integrates the fields of Preventive Cardiology with Health Psychology and Behavioral Medicine.In addition, Dr. Rozanski is a leading expert in applying Cardiac Imaging for optimal Risk Assessment and Clinical Decision Making among patients who are candidates for cardiac testing due to risk factors or symptoms which are suggesting of heart disease.Dr. Rozanski is the co-author of over 270 peer-reviewed medical articles, book chapters and medical editorials, many of which are considered seminal contributions to the fields of Cardiology and/or Health Psychology._________________________________________________Sponsor the JOWMA Podcast! Email digitalcontent@jowma.orgBecome a JOWMA Member! www.jowma.orgFollow us on Instagram! www.instagram.com/JOWMA_orgFollow us on Twitter!www.twitter.com/JOWMA_medFollow us on Facebook! https://www.facebook.com/JOWMAorgStay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VPA865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until April 26, 2026.Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Breastcancer.org. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VPA865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until April 26, 2026.Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Breastcancer.org. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VPA865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until April 26, 2026.Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Breastcancer.org. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
On this episode of the Sports Medicine Primer Series, host Dr. Zainab Shirazi, MD, continues the conversation with Dr. Dan Cushman, MD, discussing the management of a case of shoulder pain in a 23-year-old backpacker. The goal of this ongoing series is to be an audible study aid for anyone pursuing a career as a sports medicine physician and to prepare them for a sports medicine fellowship. Dr. Cushman is board-certified in both Sports Medicine and Physical Medicine & Rehabilitation, and specializes in the care of musculoskeletal injuries in both athletes & non-athletes, musculoskeletal ultrasound, electrodiagnostics, and endurance sports-specific injuries. He serves as the team physician for the University of Utah Track & Field and Cross-Country teams and is also the team physician for the University of Utah Swimming and Diving teams. Dr. Shirazi is a Sports Medicine Fellow at the University of Colorado. She completed her residency training in Physical Medicine & Rehabilitation (PM&R) at NewYork-Presbyterian Columbia/Cornell, where she served as Chief Resident, and is the current Fellow Chair for AMSSM's Library of Ultrasound Pathology. She is passionate about women's sports medicine and providing specialized care for female athletes. Resources: Best Practices in Sports Medicine: AMSSM and AOASM Case Studies (1st ed) – Case 66 (p. 395): https://amssmstore.com/best-practices-in-sports-medicine-amssm-and-aoasm-case-studies Peripheral Neuropathies of the Upper Extremity | National Fellow Online Lecture Series: https://www.youtube.com/watch?v=vC0XgHvQWXc Unilateral Winged Scapula: Clinical and Electrodiagnostic Experience with 128 cases, With Special Attention to Long Thoracic Nerve Palsy: https://onlinelibrary.wiley.com/doi/full/10.1002/mus.26059 The Natural History of Long Thoracic and Spinal Accessory Neuropathies: https://onlinelibrary.wiley.com/doi/full/10.1002/mus.10068 MR Neurography (MRN) of the Long Thoracic Nerve: Retrospective Review of Clinical Findings and Imaging Results at Our Institution Over 4 Years: https://link.springer.com/article/10.1007/s00256-017-2737-z Ortho Bullets – Scapular Winging: https://www.orthobullets.com/shoulder-and-elbow/3062/scapular-winging Surgical and Clinical Decision Making in Isolated Long Thoracic Nerve Palsy: https://journals.sagepub.com/doi/full/10.1177/1558944717733306 A Comprehensive Analysis of Pectoralis Major Transfer for Long Thoracic Nerve Palsy: https://www.sciencedirect.com/science/article/pii/S1058274614006818
On this episode of the Sports Medicine Primer Series, host Dr. Zainab Shirazi, MD, is joined by Dr. Dan Cushman, MD, to discuss how to manage a case of shoulder pain in a 23-year-old backpacker. The goal of this ongoing series is to be an audible study aid for anyone pursuing a career as a sports medicine physician and to prepare them for a sports medicine fellowship. Dr. Cushman is board-certified in both Sports Medicine and Physical Medicine & Rehabilitation, and specializes in the care of musculoskeletal injuries in both athletes & non-athletes, musculoskeletal ultrasound, electrodiagnostics, and endurance sports-specific injuries. He serves as the team physician for the University of Utah Track & Field and Cross-Country teams and is also the team physician for the University of Utah Swimming and Diving teams. Dr. Shirazi is a Sports Medicine Fellow at the University of Colorado. She completed her residency training in Physical Medicine & Rehabilitation (PM&R) at NewYork-Presbyterian Columbia/Cornell, where she served as Chief Resident, and is the current Fellow Chair for AMSSM's Library of Ultrasound Pathology. She is passionate about women's sports medicine and providing specialized care for female athletes. Resources: Best Practices in Sports Medicine: AMSSM and AOASM Case Studies (1st ed) – Case 66 (p. 395): https://amssmstore.com/best-practices-in-sports-medicine-amssm-and-aoasm-case-studies Peripheral Neuropathies of the Upper Extremity | National Fellow Online Lecture Series: https://www.youtube.com/watch?v=vC0XgHvQWXc Unilateral Winged Scapula: Clinical and Electrodiagnostic Experience with 128 cases, With Special Attention to Long Thoracic Nerve Palsy: https://onlinelibrary.wiley.com/doi/full/10.1002/mus.26059 The Natural History of Long Thoracic and Spinal Accessory Neuropathies: https://onlinelibrary.wiley.com/doi/full/10.1002/mus.10068 MR Neurography (MRN) of the Long Thoracic Nerve: Retrospective Review of Clinical Findings and Imaging Results at Our Institution Over 4 Years: https://link.springer.com/article/10.1007/s00256-017-2737-z Ortho Bullets – Scapular Winging: https://www.orthobullets.com/shoulder-and-elbow/3062/scapular-winging Surgical and Clinical Decision Making in Isolated Long Thoracic Nerve Palsy: https://journals.sagepub.com/doi/full/10.1177/1558944717733306 A Comprehensive Analysis of Pectoralis Major Transfer for Long Thoracic Nerve Palsy: https://www.sciencedirect.com/science/article/pii/S1058274614006818
Sarah Spaulding joins Ethics Talk to discuss her article, coauthored Dr Katherine Fischkoff: “How Should We Understand Regret as a Moral Psychological Experience That Can Influence Clinical Decision-Making?” Recorded January 9, 2024. Read the article for free at JournalOfEthics.org
Dr. E is joined by his new co-host and good friend, Dr. Sean Wells, from Nutritional Physical Therapy. They talk about two ankle cases, both injuries. Dr. E discovered an old classic reset helped both cases WB with significantly less pain. Then they discuss this article by Dr. Tom Michaud, DC and how it has impacted their practice and Clinical Decision Making.Untold Physio Stories is sponsored byComprehend PT- Leave Comprehend PT running in the background or record audio when you have time. The AI based SOAP note generator does the rest! No need for accuracy or exact wording! It's a game changer and will give you more time with your patients! Use code MMT50 to save 50% off your first month. Free trial available at sign up!The Eclectic Approach Network - Check out Dr. E's all new private, non tracking and ad free network for rehab pros! It's free to join, has chat, feed, and all the features of other social networks without the creeping tracking.Check out EDGE Mobility System's Best Sellers - Something for every PT, OT, DC, MT, ATC or Fitness Minded Individual https://edgemobilitysystem.com
Could the key to more effective allergy therapies lie in the nasal microbiome? In this episode of BackTable ENT, Dr. Jennifer Villwock from Kansas University Medical Center discusses the intricacies of treating allergies and sinus issues with hosts Dr. Ashley Agan and Dr. Gopi Shah. --- SYNPOSIS Dr. Villwock begins by highlighting the importance of personalized medicine and the role of the microbiome in immunotherapy. Topics include topical and oral probiotics, the nasal microbiome, intralymphatic immunotherapy, and the significance of accurate allergy testing. Dr. Villwock also shares insights on sublingual and subcutaneous immunotherapy, the future of allergy treatments, and the impact of environmental factors on sinus health. --- TIMESTAMPS 00:00 - Introduction 01:53 - Understanding the Sinus Microbiome 04:34 - The Role of the Microbiome in Health 09:31 - Challenges in Microbiome Research 23:21 - Clinical Decision-Making in Antibiotic Use 25:07 - Exploring Probiotics & Dietary Factors for Sinus Health 30:12 - Immunotherapy and Microbiome 35:47 - Allergy Testing Methods 41:40 - Future Directions in Immunotherapy 44:18 - Conclusion and Final Thoughts --- RESOURCES Jennifer Villwock Profile https://www.kumc.edu/jvillwock.html AAOA 2025 Explorers Course in Allergy and Immunology, Vail, CO. March 27-29, 2025 https://www.aaoallergy.org/education/aaoa-explorers-course-2025/ BackTable+ for ENT https://plus.backtable.com/pages/ent Check out BackTable+ for ENT, our sponsor and new e-learning platform! https://plus.backtable.com/pages/ent
In this episode of the PFC podcast, Dr. Jim DeCanto, an experienced anesthesiologist, discusses the critical aspects of airway management in emergency situations. He emphasizes the importance of decision-making processes, assessing neurological status, and the necessity of proper planning and preparation for airway interventions. The conversation highlights the challenges faced in both hospital and pre-hospital settings, the significance of having the right equipment, and the need for practitioners to be confident in their skills. Dr. DeCanto shares valuable insights and advice for new practitioners in the field, stressing the importance of thorough assessments and timely interventions to ensure patient safety. Takeaways Airway management is a critical skill for anesthesiologists. Decision-making in emergencies can be complex and requires a plan. Assessing neurological status is crucial before airway interventions. Proper planning and preparation can enhance confidence in emergency situations. Communication with patients, even when unconscious, is important. Practitioners must be ready to act when necessary, as no one else may be available. Understanding the tools and techniques for airway management is essential. Experience and continuous learning are key to improving skills in airway management. Practitioners should not hesitate to perform necessary procedures when indicated. Physical exams and clinical judgment are vital in emergency medicine. Chapters 00:00 Introduction to Airway Management 03:05 Decision-Making in Emergency Situations 12:29 Assessing Neurological Status 20:40 Planning and Preparing for Airway Management 30:50 Clinical Decision-Making in Airway Management 41:21 Advice for New Practitioners Thank you to Delta Development Team for in part, sponsoring this podcast. deltadevteam.com For more content go to www.prolongedfieldcare.org Consider supporting us: patreon.com/ProlongedFieldCareCollective or www.lobocoffeeco.com/product-page/prolonged-field-care
In this episode of the 3 Pie Squared - ABA Business Leaders podcast, we sit down with Amanda Ralston, founder of Nonbinary Solutions and creator of Knowetic.AI, to discuss how AI is transforming clinical decision-making in the ABA field. Amanda shares her insights on balancing innovation and ethics, building effective clinical tools, and the importance of quality in ABA services. Learn how Knowetic.AI supports clinicians by providing structured pathways to improve patient outcomes and ensure medical necessity. Whether you're a seasoned practitioner or just starting your journey, Amanda's unique perspective and wealth of experience will inspire and inform your practice. Don't miss this conversation about the intersection of technology, clinical expertise, and patient care. Want to learn more about NonBinary Solutions? Check out Knowetic AI! Knowetic.AI, a clinical decision support system helping clinicians streamline their processes and enhance patient outcomes. Learn more at www.knowetic.ai. Starting a practice or looking to enhance your existing one? Download our free startup list here. Access exclusive resources for ABA business leaders by exploring membership options with 3 Pie Squared here.
In this episode of the PFC Podcast, Dennis and Alex discuss the complexities of trauma surgery, particularly focusing on pelvic injuries and the use of pelvic binders. They explore the subjective nature of truth in medical practice, the importance of research and evidence in trauma care, and the anatomy and physiology related to pelvic injuries. The conversation delves into injury patterns, damage control surgery, and the challenges faced in operational environments. They also engage in a debate about the efficacy of pelvic binders, weighing the evidence and risks involved in their use during trauma care. In this conversation, Dennis discusses the critical importance of evidence-based practice in combat medicine, particularly regarding the use of pelvic binders. He emphasizes the need for medical professionals to understand the nuances of pelvic injuries, especially in a combat environment, and how these injuries differ from civilian cases. The discussion also covers the structured approach to prolonged field care, the management of blood transfusions, and the challenges of imaging in trauma assessment. Dennis advocates for clinical decision-making that prioritizes patient safety and effective care, while also acknowledging the emotional weight of these decisions in high-stakes environments. Takeaways Truth is subjective and varies by perception. Disagreement in medical practice can lead to better patient care. Understanding research quality is crucial in medical decisions. Venous bleeding is more common in pelvic injuries than arterial. Damage control surgery involves multiple phases of patient management. Operational environments present unique challenges for trauma care. Pelvic binders are debated in their effectiveness and necessity. Surgical decision-making requires weighing risks and benefits. Evidence-based medicine is essential but often lacking in operational settings. The role of pelvic binders in trauma care remains contentious. Evidence is crucial in medical practice to avoid misinformation. Dismounted IED blasts result in unique injury patterns. Understanding research and statistics is essential for medical professionals. Pelvic binders may not always be beneficial in every injury case. Timely blood transfusions are critical in managing trauma patients. Imaging plays a vital role in assessing pelvic injuries. Clinical decision-making should be based on patient stability and evidence. Prolonged field care requires a structured approach to patient management. Team collaboration is essential in making difficult medical decisions. Continuous education and training are vital for operational medics. Chapters 00:00 Introduction to the Podcast and Guest 02:58 Understanding Trauma Surgery and Pelvic Injuries 06:13 Research and Evidence in Trauma Care 09:06 Anatomy and Physiology of Pelvic Injuries 12:04 Injury Patterns and Their Implications 14:53 Damage Control Surgery and Patient Management 17:48 Operational Environment Challenges 21:03 The Role of Pelvic Binders in Trauma Care 23:52 Debate on Pelvic Binders and Evidence 26:51 Surgical Decision Making in Trauma 29:47 Conclusion and Final Thoughts 45:19 The Importance of Evidence in Medical Practice 52:34 Understanding Pelvic Injuries in Combat 53:59 Prolonged Field Care: A Structured Approach 01:00:03 Managing Blood Transfusions in Critical Care 01:10:06 The Role of Imaging in Trauma Assessment 01:18:00 Clinical Decision-Making in Prolonged Field Care For more content go to www.prolongedfieldcare.org Consider supporting us: patreon.com/ProlongedFieldCareCollective or www.lobocoffeeco.com/product-page/prolonged-field-care
Dr. Alan Rozanski is Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Chief Academic Officer, Executive Director of Cardiac Education and Fellowship Training Programs, and Director of Nuclear Cardiology for the Department of Cardiology at Mount Sinai St. Lukes. A graduate of Yale University and the Tufts University School of Medicine, Dr. Rozanski completed his Internal Medicine and Cardiology Fellowship training at Mount Sinai Hospital and a fellowship in Nuclear Medicine at Cedars-Sinai Medical Center in Los Angeles. While at Cedars-Sinai Medical Center, Dr. Rozanski founded a large multi-disciplinary program in Preventive and Rehabilitative Cardiology and initiated research which helped lead to the creation of a new field of Behavioral Cardiology. This led to a prestigious Sabbatical Fellowship from the MacArthur Foundation to study the determinants of health-promoting and health-damaging behaviors alongside many leading behavioral clinicians across the nation. In 1990, Dr. Rozanski joined the cardiology staff of St. Lukes/Roosevelt Hospital (now Mount Sinai St. Lukes and Mount Sinai West Hospitals) where he eventually served as Chief of Cardiology before assuming his current positions. Dr. Rozanski is noted for his unique clinical and academic focus and novel research that uniquely integrates the fields of Preventive Cardiology with Health Psychology and Behavioral Medicine. In addition, Dr. Rozanski is a leading expert in applying Cardiac Imaging for optimal Risk Assessment and Clinical Decision Making among patients who are candidates for cardiac testing due to risk factors or symptoms which are suggesting of heart disease. Dr. Rozanski is the co-author of over 270 peer-reviewed medical articles, book chapters and medical editorials, many of which are considered seminal contributions to the fields of Cardiology and/or Health Psychology.